Prodrug > 통합검색

통합검색

한빛사

내가 찾은 검색어

1Prodrug

'Prodrug' 에 대한 통합검색결과 87건입니다.

한빛사87건

최신순
관련도순

Dual Delivery of Light/Prodrug Nanoparticles Using Tumor-Implantable Micro Light-Emitting Diode on an Optofluidic System for Combinational Glioma Trea
- ACS Nano Apr 28 2025, | https://doi.org/10.1021/acsnano.4c17421
- 2025.04
- 바이오·의료융합
Tumor-specific biochemical nanoconversion of self-assembled peptide-conjugated paclitaxel-docetaxel-based nanoparticles
- Nano Converg. Apr 26 2025, 12 (1) | https://doi.org/10.1186/s40580-025-00487-0
- 2025.04
- 의약학
Programable Prodrug Nanomodulator Targets Tumor Redox Homeostasis Imbalance to Amplify Disulfidptosis and Immunogenic Pyroptosis for Breast Tumor Immu
- Adv. Healthc. Mater. Mar 20 2025, | https://doi.org/10.1002/adhm.202500272
- 2025.03
- 바이오·의료융합
Breaking barriers: Nitric oxide-releasing nanocomplexes for collagen degradation and enhanced αPD-L1 immunotherapy in deep tumor
- J. Control. Release Available online 24 February 2025 | https://doi.org/10.1016/j.jconrel.2025.02.072
- 2025.02
- 바이오·의료융합
- 강래형(University of Wisconsin, 단국대학교)
Crystallization of supersaturated PEG-b-PLA for the production of drug-loaded polymeric micelles
- J. Control. Release Feb 11 2025, 380 S0168-3659(25)00113-0 | https://doi.org/10.1016/j.jconrel.2025.02.009
- 2025.02
- 바이오·의료융합
Drug repositioning of mesalamine via supramolecular nanoassembly for the treatment of drug-induced acute liver failure
- Theranostics 2025; 15(3):1122-1134 | https://www.thno.org/v15p1122
- 2025.01
- 바이오·의료융합
Human serum albumin-3-amino-1-propanesulfonic acid conjugate inhibits amyloid-β aggregation and mitigates cognitive decline in Alzheimer‘s disease
- J. Control. Release Jan 16 2025, 379 S0168-3659(25)00021-5 | https://doi.org/10.1016/j.jconrel.2025.01.019
- 2025.01
- 의약학
- Batakrishna Jana(UNIST)
- 유자형(UNIST)
Host-Guest Adduct as a Stimuli-Responsive Prodrug: Enzyme-Triggered Self-Assembly Process of a Short Peptide Within Mitochondria to Induce Cell Apopto
- Adv. Healthc. Mater. Nov 06 2024, | https://doi.org/10.1002/adhm.202403243
- 2024.11
- 바이오·의료융합
- Hy Dinh Nguyen(아주대학교)
  Interview
- 이범진(아주대학교)
Novel pH-Responsive Structural Rearrangement of Myristic Acid-Conjugated Quetiapine Nanosuspension for Enhanced Long-Acting Delivery Performance
- Adv. Sci. Sep 03 2024, | https://doi.org/10.1002/advs.202405200
- 2024.09
- 의약학
Hy Dinh Nguyen

아주대학교

Quetiapine (QTP) is a first-line antipsychotic drug for the treatment of schizophrenia; however, lifelong daily administration of QTP tablets is associated with a low patient acceptance profile. Accordingly, substituting oral dosage forms with long-acting injectables can potentially improve patient compliance and treatment effectiveness.
- Adv. Sci.
- 2024.09.11
A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectru
- ACS Central Sci. Aug 28 2024, 10 (8) | https://doi.org/10.1021/acscentsci.4c00548
- 2024.08
- 바이오·의료융합
Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs
- Theranostics Published 2024-8-26;14(14):5413-5428 | doi:10.7150/thno.97269
- 2024.08
- 바이오·의료융합
Dexamethasone nanocrystals-embedded hydroxypropyl methylcellulose hydrogel increases cochlear delivery and attenuates hearing loss following intratymp
- Carbohydr. Polym. 3 August 2024, 345 S0144-8617(24)00772-0 | https://doi.org/10.1016/j.carbpol.2024.122546
- 2024.08
Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease
- ACS Nano June 12, 2024 | https://doi.org/10.1021/acsnano.4c05544
- 2024.06
- 바이오·의료융합
Light-Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy
- Adv. Mater. Jun 19 2024, | https://doi.org/10.1002/adma.202405475
- 2024.06
- 바이오·의료융합
Implantable MicroLED-Mediated Chemo-Photodynamic Combination Therapy for Glioma Treatment
- Adv. Funct. Mater. 16 June 2024 | https://doi.org/10.1002/adfm.202316386
- 2024.06
- 바이오·의료융합
임한솔

건국대학교

해당 논문은 나노기술을 이용하여 암 치료의 효율성과 정확성을 향상시키는 데 중점을 두고 있습니다. 이 분야는 현재 의학과 공학, 생명과학의 교차점에서 빠르게 발전하고 있으며, 특히 암과 같은 복잡한 질병을 대상으로 하는 표적 치료법 개발에 매우 중요한 역할을 하고 있습니다. 나노입자를 이용한 약물 전달 시스템은 높은 선택성과 특이성을 제공하여 건강한 조직에 미치는 부작용을 최소화하면서 암 세포에 더 많은 약물을 전달할 수 있는 잠재력을 가지고 있습니다.
- Nano Today
- 2024.06.19
- 김누리(전북대학교)
- 이동원(전북대학교)
Tumor-targeted and stimulus-responsive polymeric prodrug nanoparticles to enhance the anticancer therapeutic efficacy of doxorubicin
- J. Control. Release Volume 369, May 2024, Pages 351-362 | https://doi.org/10.1016/j.jconrel.2024.03.046
- 2024.05
- 바이오·의료융합
- 황인영(National University of Singapore)
- 장욱(National University of Singapore)
Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy
- Nat. Commun. 21 May 2024 | https://doi.org/10.1038/s41467-024-48661-y
- 2024.05
Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy
- J. Nanobiotechnol. Mar 13 2024, 22 (1) 109 | https://doi.org/10.1186/s12951-024-02314-w
- 2024.03
- 바이오·의료융합